THE FIRST MAJOR DEVELOPMENT IN 20 YEARS TO HELP MANAGE CHRONIC KIDNEY DISEASE IN PATIENTS AT RISK OF PROGRESSION WITH AND WITHOUT TYPE 2 DIABETES
